Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Matthew Clark

Matthew Clark

Life Sciences R&D Solution Consultant

Connect with Matthew Clark on LinkedIn
Website:

About the author:

Matthew Clark, Ph. D, Life Sciences R&D Solution Consultant

Matthew has extensive experience working in pharmaceutical research in informatics, patient safety, and drug design. He is the author of many publications dealing with predictive models. At Elsevier he uses this experience to design and implement information solutions for customers.


Posts by Matthew Clark

AI in the life sciences – the good, the bad and the ugly

Posted on November 7th, 2018 in Pharma R&D

Everyone in the life science industry – from the C-suite in the boardroom to scientists at the bench – are talking about the potential of AI, especially now they’re starting to see pharma companies using the technology. And we are beginning to see researchers mixing diverse kinds of data together – images, text and numeric data to name a few – to learn from. Continue reading “AI in the life sciences – the good, the bad and the ugly” »

Using data for good to solve humanitarian issues

Posted on October 16th, 2018 in Pharma R&D

Researchers are increasingly using their domain expertise to tackle many of the world’s problems such as hunger, pandemics and other societal issues. When I worked for a pharma company I was continually surprised experienced pharmacologists could tell me which toxicology events in animals were predictive of human responses and which events could be safely ignored. Continue reading “Using data for good to solve humanitarian issues” »

The Future of Chemistry R&D Will Depend on Deep Learning

Posted on June 7th, 2018 in Pharma R&D

A recent survey of chemists, carried out by Elsevier’s Reaxys team, showed that only 13% identified a familiarity with machine learning (or similar technologies) as being important for future chemists. Continue reading “The Future of Chemistry R&D Will Depend on Deep Learning” »

How Pharma Can Make the Most of Gene Tech CRISPR

Posted on December 18th, 2017 in Pharma R&D

puzzle-2500333_960_720

The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. Continue reading “How Pharma Can Make the Most of Gene Tech CRISPR” »

  1. 1
  2. 2